In this issue:
Preladenant in PD and motor fluctuations
Pramipexole for depressive symptoms in PD
Donepezil for reducing falls in PD
Glycopyrrolate for sialorrhea in PD
Trends of antiparkinson drug usage in Australia
Therapeutic potential of targeting group III mGlu rec
Please login below to download this issue (PDF)